News & Publications for:

Beau Ances

A better screening tool for HIV-associated neurocognitive disorders: is it what clinicians need?

Posted on January 8, 2015

Brouillette, M.-J., Mayo, N., Fellows, L.K., Lebedeva, E., Higgins, J., Overton, E.T., Ances, B.M., Koski, L.; 2014 AIDS, Read More

Posted in: HPAN, Neurodegeneration, Publications Faculty:

Brain morphometric correlates of metabolic variables in HIV: the CHARTER study

Posted on January 8, 2015

S. L. Archibald, J. A. McCutchan, C. Sanders, T. Wolfson, T. L. Jernigan, R. J. Ellis, B. M. Ances, A. C. Collier, J. C. McArthur, S. Morgello, D. M. Simpson, C. Marra, B. B. Gelman, D. B. Clifford, I. Grant, C. Fennema-Notestine; 2014 Journal of NeuroVirology, 20(6), pp603-611 Read More

Posted in: HPAN, Neurodegeneration, Publications Faculty:

Partial volume correction in quantitative amyloid imaging

Posted on January 8, 2015

Yi Su, Tyler M. Blazey, Abraham Z. Snyder, Marcus E. Raichle, Daniel S. Marcus, Beau M. Ances, Randall J. Bateman, Nigel J. Cairns, Patricia Aldea, Lisa Cash, Jon J. Christensen, Karl Friedrichsen, Russ C. Hornbeck, Angela M. Farrar, Christopher J. Owen, Richard Mayeux, Adam M. Brickman, William Klunk, Julie C. Price, Paul M. Thompson, Bernadino Ghetti; 2015, NeuroImage, Volume 107, pp 55-64 Read More

Posted in: HPAN, Neurodegeneration, Neurogenetics, Publications Faculty: , , , ,

Impact of the HIV Tat C30C31S dicysteine substitution on neuropsychological function in patients with clade C disease

Posted on November 13, 2014

Paul RH, Joska JA, Woods C, Seedat S, Engelbrecht S, Hoare J, Heaps J, Valcour V, Ances B, Baker LM, Salminen LE, Stein DJ; 2014 Journal of NeuroVirology, 10.1007/s13365-014-0293-z Read More

Posted in: HPAN, Neurodegeneration, Publications Faculty:

Washington People: Beau Ances

Posted on November 3, 2014

From the WUSTL Newsroom… Next year, the population of U.S. patients infected with human immunodeficiency virus (HIV) will reach a remarkable milestone: More than half of the patients infected with the virus will be 50 years of age or older. As this population ages, problems for long-term survivors of HIV infection are becoming apparent. One of the most alarming challenges has been a significant increase in difficulties with thinking and memory. Beau Ances, MD, PhD, associate … Read More

Posted in: HPAN, Neurodegeneration, News Faculty: